Jennifer Ott, PharmD, BCPS Clinical Pharmacy Specialist, Infectious Diseases Eastern Maine Medical...

22
ANTIBIOTIC SELECTION AND RESISTANCE: A PHARMACIST’S PERSPECTIVE Jennifer Ott, PharmD, BCPS Clinical Pharmacy Specialist, Infectious Diseases Eastern Maine Medical Center Bangor, ME [email protected]

Transcript of Jennifer Ott, PharmD, BCPS Clinical Pharmacy Specialist, Infectious Diseases Eastern Maine Medical...

Page 1: Jennifer Ott, PharmD, BCPS Clinical Pharmacy Specialist, Infectious Diseases Eastern Maine Medical Center Bangor, ME jott@emh.org.

ANTIBIOTIC SELECTION AND RESISTANCE: A

PHARMACIST’S PERSPECTIVEJennifer Ott, PharmD, BCPS

Clinical Pharmacy Specialist, Infectious DiseasesEastern Maine Medical Center

Bangor, [email protected]

Page 2: Jennifer Ott, PharmD, BCPS Clinical Pharmacy Specialist, Infectious Diseases Eastern Maine Medical Center Bangor, ME jott@emh.org.

The use of antibiotics is the single most important factor leading to antibiotic resistance

Up to 50% of all antibiotics prescribed are not needed or are not optimally effective as prescribed

CDC. Threat Report 2013. http://www.cdc.gov/drugresistance/threat-report-2013/

Page 3: Jennifer Ott, PharmD, BCPS Clinical Pharmacy Specialist, Infectious Diseases Eastern Maine Medical Center Bangor, ME jott@emh.org.

Increased Use of Vancomycin Associated with Resistance

0

50

100

150

200

250

1990 1991 1992 1993 1994 1995

Nu

mb

er

of

pa

tie

nts

wit

h V

RE

60

65

70

75

80

85

De

fin

ed

da

ily d

os

es

of

va

nc

om

yc

in/1

00

0 p

ati

en

t d

ay

s

Patients with VRE DDD vancomycin

Kim NJ. JID 1999;179:163

Page 4: Jennifer Ott, PharmD, BCPS Clinical Pharmacy Specialist, Infectious Diseases Eastern Maine Medical Center Bangor, ME jott@emh.org.

N. gonorrhoeae Resistance in the United States 1987-2011

The Gonococcal Isolate Surveillance Project

Page 5: Jennifer Ott, PharmD, BCPS Clinical Pharmacy Specialist, Infectious Diseases Eastern Maine Medical Center Bangor, ME jott@emh.org.

Individuals prescribed an antibiotic in primary care for a respiratory or urinary infection develop resistance to that antibiotic Greatest effect in the month immediately

following treatment but may persist for up to 12 months

Costelloe, C. et al. BMJ 2010: 340:c2096.

Page 6: Jennifer Ott, PharmD, BCPS Clinical Pharmacy Specialist, Infectious Diseases Eastern Maine Medical Center Bangor, ME jott@emh.org.

Effect of Antibiotic Prescribing in Primary Care on Antimicrobial Resistance

Costelloe C et al. BMJ. 2010;340:c2096.

Page 7: Jennifer Ott, PharmD, BCPS Clinical Pharmacy Specialist, Infectious Diseases Eastern Maine Medical Center Bangor, ME jott@emh.org.

Nursing Home Patients Example

1 Centers for Medicare and Medicaid Services, Long Term Care Minimum Data Set, Resident profile table as of 05/02/2005. Baltimore. MD. 2 Loeb, M et.al. Antibiotic use in Ontario facilities that provide chronic care. J Gen Intern Med 2001; 16: 376-383. 3 Centers for Disease Control and Prevention, National Center for Health statistics, 1999 National Nursing Home Survey. Nursing Home Residents, number, percent distribution, and rate per 10,000, by age at interview, according to sex, race, and region: United States, 1999.

Page 8: Jennifer Ott, PharmD, BCPS Clinical Pharmacy Specialist, Infectious Diseases Eastern Maine Medical Center Bangor, ME jott@emh.org.

Acinetobacter Resistance to Imipenem

http://www.cdc.gov/getsmart/campaign-materials/week/images/resistance.png

Page 9: Jennifer Ott, PharmD, BCPS Clinical Pharmacy Specialist, Infectious Diseases Eastern Maine Medical Center Bangor, ME jott@emh.org.

Inappropriate Dosing May Lead to Resistance

Data pooled from 4 studies Gram-negative pneumonia Ciprofloxacin resistance associated with AUC/MIC

<100

Thomas JK, et al. Antimicrob Agents Chemother. 1998;42:521-527.

Page 10: Jennifer Ott, PharmD, BCPS Clinical Pharmacy Specialist, Infectious Diseases Eastern Maine Medical Center Bangor, ME jott@emh.org.

Dosing Matters – Penicillin Example

Penicillin half-life is only 30-45 minutes Retrospective review of Streptococcal

infective endocarditis Penicillin given every 4 hours was associated

with successful treatment vs every 6 hours (OR 2.79; 95%CI 1.43-5.62)

Sandoe JAT, et al. J Antimicrob Chemother. 2013; June 13 [Epub ahead of print]

Page 11: Jennifer Ott, PharmD, BCPS Clinical Pharmacy Specialist, Infectious Diseases Eastern Maine Medical Center Bangor, ME jott@emh.org.

Pseudomonas aeruginosa MIC Distribution

Page 12: Jennifer Ott, PharmD, BCPS Clinical Pharmacy Specialist, Infectious Diseases Eastern Maine Medical Center Bangor, ME jott@emh.org.

Dosing Optimization Example

Shea KM, et al. Ann Pharmacother 2009;43:1747-1754

Page 13: Jennifer Ott, PharmD, BCPS Clinical Pharmacy Specialist, Infectious Diseases Eastern Maine Medical Center Bangor, ME jott@emh.org.

Optimizing Dosing – Cefepime Example

Cefepime Tertiary references suggest a dose of 1-2 g q8-

12h Susceptibility breakpoints are based on 1 g

q8h (= 2g q12h) Meaning: using 1 g q12h for pneumonia does

not optimize the dosing of cefepime and risks undertreating the patient

Page 14: Jennifer Ott, PharmD, BCPS Clinical Pharmacy Specialist, Infectious Diseases Eastern Maine Medical Center Bangor, ME jott@emh.org.

Current Antibiotic Resistance Threat in the United States

CDC. Threat Report 2013. http://www.cdc.gov/drugresistance/threat-report-2013/

Page 15: Jennifer Ott, PharmD, BCPS Clinical Pharmacy Specialist, Infectious Diseases Eastern Maine Medical Center Bangor, ME jott@emh.org.

BAD BUGS, NO DRUGS

As Antibiotic Discovery Stagnates…A Public Health Crisis Brews

Boucher HW, et al. Clin Infect Dis 2009;48:1-12.

Page 16: Jennifer Ott, PharmD, BCPS Clinical Pharmacy Specialist, Infectious Diseases Eastern Maine Medical Center Bangor, ME jott@emh.org.

The AntibioticPipeline

http://www.rff.org/RFF/Documents/ETC-06.pdf Accessed Jan 1, 2013

Page 17: Jennifer Ott, PharmD, BCPS Clinical Pharmacy Specialist, Infectious Diseases Eastern Maine Medical Center Bangor, ME jott@emh.org.

Anti-infective Stewardship

Promotion of appropriate and responsible use of anti-infective agents Optimize anti-infective therapy

Drug Dose Route Duration

Patient tolerance and safety Limit preventable adverse events Drug-drug or drug-disease interactions

Page 18: Jennifer Ott, PharmD, BCPS Clinical Pharmacy Specialist, Infectious Diseases Eastern Maine Medical Center Bangor, ME jott@emh.org.

Questions

Page 19: Jennifer Ott, PharmD, BCPS Clinical Pharmacy Specialist, Infectious Diseases Eastern Maine Medical Center Bangor, ME jott@emh.org.
Page 20: Jennifer Ott, PharmD, BCPS Clinical Pharmacy Specialist, Infectious Diseases Eastern Maine Medical Center Bangor, ME jott@emh.org.

Are Antibiotics Really Benign?

CDC. Threat Report 2013. http://www.cdc.gov/drugresistance/threat-report-2013/

Page 21: Jennifer Ott, PharmD, BCPS Clinical Pharmacy Specialist, Infectious Diseases Eastern Maine Medical Center Bangor, ME jott@emh.org.

Infections with Resistant Organisms are on the Rise

Page 22: Jennifer Ott, PharmD, BCPS Clinical Pharmacy Specialist, Infectious Diseases Eastern Maine Medical Center Bangor, ME jott@emh.org.

Objectives

Antibiotic overuse promotes resistance Goal – use most narrow spectrum agent for

appropriate duration Increased resistant organisms are on the rise Inappropriate antibiotic dosing may promote

resistance Antibiotic pipeline is diminishing What to do

Promote appriopriate anti-infective use Use most narrow spectrum anti-infective agent at

optimal doses for the appropriate duration